Journal Article
. 2017 Apr;9().
doi: 10.2147/BCTT.S123785.

An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors

Theresa A Koleck 1 Catherine M Bender 1 Beth Z Clark 2 Christopher M Ryan 3 Puja Ghotkar 1 Adam Brufsky 4 Priscilla F McAuliffe 4 Priya Rastogi 4 Susan M Sereika 1 Yvette P Conley 1 
  • PMID: 28424560
  •     75 References
  •     8 citations


Purpose: Inspired by the hypothesis that heterogeneity in the biology of breast cancers at the cellular level may account for cognitive dysfunction symptom variability in survivors, the current study explored relationships between host single-nucleotide polymorphisms (SNPs) in 25 breast cancer-related candidate genes (AURKA, BAG1, BCL2, BIRC5, CCNB1, CD68, CENPA, CMC2, CTSL2, DIAPH3, ERBB2, ESR1, GRB7, GSTM1, MELK, MKI67, MMP11, MYBL2, NDC80, ORC6, PGR, RACGAP1, RFC4, RRM2, and SCUBE2), identified from clinically relevant prognostic multigene-expression profiles for breast cancer, and pretreatment cognitive performance.

Patients And Methods: The sample (n=220) was comprised of 138 postmenopausal women newly diagnosed with early stage breast cancer and 82 postmenopausal age- and education-matched healthy controls without breast cancer. Cognitive performance was assessed after primary surgery but prior to initiation of adjuvant chemotherapy and/or hormonal therapy using a comprehensive battery of neuropsychological tests encompassing eight cognitive function composite domains: attention, concentration, executive function, mental flexibility, psychomotor speed, verbal memory, visual memory, and visual working memory. In total, 131 SNPs were included in the analysis. Standard and robust multiple linear regression modeling was used to examine relationships between each domain and the presence or absence of one or more minor alleles for each SNP. Genetic risk/protection scores (GRSs) were calculated for each domain to evaluate the collective effect of possession of multiple risk/protective alleles.

Results: With the exception of CMC2, MMP11, and RACGAP1, significant (P<0.05) SNP main effect and/or SNP by future prescribed treatment group interactions were observed for every gene between at least one domain and one or more SNPs. All GRSs were found to be significantly (P<0.001) associated with each respective domain score.

Conclusion: Associations between host SNPs and computed GRSs and variability in pretreatment cognitive function performance support the study hypothesis, and warrant further investigations to identify biomarkers for breast cancer-related cognitive dysfunction.

Keywords: biomarkers; breast neoplasms; cognition; genetics.

Regulation of neuron survival and death by p130 and associated chromatin modifiers.
David X Liu, Niharika Nath, Srikumar P Chellappan, Lloyd A Greene.
Genes Dev, 2005 Mar 17; 19(6). PMID: 15769944    Free PMC article.
B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer.
Arturo Sala.
Eur J Cancer, 2005 Oct 04; 41(16). PMID: 16198555
rs12976445 variant in the pri-miR-125a correlates with a lower level of hsa-miR-125a and ERBB2 overexpression in breast cancer patients.
Tomasz P Lehmann, Konstanty Korski, +3 authors, Paweł P Jagodziński.
Oncol Lett, 2013 Feb 20; 5(2). PMID: 23420759    Free PMC article.
A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.
Ke-Da Yu, Gen-Hong Di, +5 authors, Zhi-Ming Shao.
FASEB J, 2009 Feb 21; 23(7). PMID: 19228880
Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
Olivia Fletcher, Nichola Johnson, +26 authors, Julian Peto.
J Natl Cancer Inst, 2011 Jan 26; 103(5). PMID: 21263130
Highly Cited.
Current evidence on the association between rs3757318 of C6orf97 and breast cancer risk: a meta-analysis.
Yuan Hong, Xue-Qin Chen, +5 authors, Wei Chen.
Asian Pac J Cancer Prev, 2014 Oct 24; 15(19). PMID: 25338983
Patterns of change in cognitive function with anastrozole therapy.
Catherine M Bender, John D Merriman, +11 authors, Susan M Sereika.
Cancer, 2015 Apr 25; 121(15). PMID: 25906766    Free PMC article.
A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition.
Erin E Sundermann, Pauline M Maki, Jeffrey R Bishop.
Menopause, 2010 Jul 10; 17(4). PMID: 20616674    Free PMC article.
Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors.
Brent J Small, Kerri Sharp Rawson, +5 authors, Paul B Jacobsen.
Cancer, 2011 Mar 23; 117(7). PMID: 21425136
B-myb and C-myb play required roles in neuronal apoptosis evoked by nerve growth factor deprivation and DNA damage.
David X Liu, Subhas C Biswas, Lloyd A Greene.
J Neurosci, 2004 Oct 08; 24(40). PMID: 15470138    Free PMC article.
Worldwide distribution of allelic variation at the progesterone receptor locus and the incidence of female reproductive cancers.
L Christie Rockwell, Elizabeth J Rowe, +6 authors, Joseph G Lorenz.
Am J Hum Biol, 2011 Nov 29; 24(1). PMID: 22121098
Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, +17 authors, Philip S Bernard.
J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204204    Free PMC article.
Highly Cited.
Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.
Theresa A Koleck, Catherine M Bender, +5 authors, Yvette P Conley.
Oncol Nurs Forum, 2014 Oct 31; 41(6). PMID: 25355028    Free PMC article.
Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population.
Jing Han, Tao Jiang, +5 authors, Hongbing Shen.
Breast Cancer Res Treat, 2011 Apr 30; 129(3). PMID: 21528353
The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.
Tim A Ahles, Andrew J Saykin, +4 authors, Leila A Mott.
Psychooncology, 2003 Aug 19; 12(6). PMID: 12923801
C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patients.
Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, +6 authors, Hirotaka Iwase.
Eur J Hum Genet, 2014 Nov 06; 23(7). PMID: 25370037    Free PMC article.
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.
Marc Buyse, Sherene Loi, +18 authors, TRANSBIG Consortium.
J Natl Cancer Inst, 2006 Sep 07; 98(17). PMID: 16954471
Highly Cited.
Common breast cancer susceptibility loci are associated with triple-negative breast cancer.
Kristen N Stevens, Celine M Vachon, +81 authors, Fergus J Couch.
Cancer Res, 2011 Aug 17; 71(19). PMID: 21844186    Free PMC article.
BCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injury.
Nicole Zangrilli Hoh, Amy K Wagner, +5 authors, Yvette P Conley.
J Neurotrauma, 2010 May 28; 27(8). PMID: 20504155    Free PMC article.
Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification.
Mohammed A Aleskandarany, D Soria, +4 authors, E A Rakha.
Breast Cancer Res Treat, 2015 May 09; 151(2). PMID: 25953687
Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis.
Carlos Silvestre-Roig, Patricia Fernández, +12 authors, Vicente Andrés.
Circ Cardiovasc Genet, 2014 Jan 08; 7(1). PMID: 24395923
Gene expression profiling predicts clinical outcome of breast cancer.
Laura J van 't Veer, Hongyue Dai, +13 authors, Stephen H Friend.
Nature, 2002 Feb 02; 415(6871). PMID: 11823860
Highly Cited.
Progesterone receptor variants associated with the PROGINS haplotype exhibit functional properties similar to those of wild-type progesterone receptor.
Justus Stenzig, Andreas Schweikert, +3 authors, Thomas Rau.
Pharmacogenet Genomics, 2012 Jun 23; 22(8). PMID: 22722322
Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.
Andrew Tutt, Alice Wang, +21 authors, Fred Waldman.
BMC Cancer, 2008 Nov 26; 8. PMID: 19025599    Free PMC article.
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received.
S-J Dawson, N Makretsov, +17 authors, P Pharoah.
Br J Cancer, 2010 Jul 29; 103(5). PMID: 20664598    Free PMC article.
Highly Cited.
Correlates of everyday memory among residents of Part III homes.
J Cockburn, P T Smith.
Br J Clin Psychol, 1993 Feb 01; 32(1). PMID: 8467276
DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.
Martin H Hager, Samantha Morley, +14 authors, Michael R Freeman.
EMBO Mol Med, 2012 May 18; 4(8). PMID: 22593025    Free PMC article.
A simple salting out procedure for extracting DNA from human nucleated cells.
S A Miller, D D Dykes, H F Polesky.
Nucleic Acids Res, 1988 Feb 11; 16(3). PMID: 3344216    Free PMC article.
Highly Cited.
Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study.
Maria B Lyng, Anne-Vibeke Lænkholm, +4 authors, Henrik J Ditzel.
PLoS One, 2013 Jan 24; 8(1). PMID: 23342080    Free PMC article.
Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone.
Mary Lou Voytko, Rhonda Murray, Casey J Higgs.
J Neurosci, 2009 Aug 21; 29(33). PMID: 19692611    Free PMC article.
Cognitive functioning and sex steroid hormone gene polymorphisms in women at midlife.
Howard M Kravitz, Peter M Meyer, +2 authors, MaryFran R Sowers.
Am J Med, 2006 Sep 05; 119(9 Suppl 1). PMID: 16949394
Oestrogen alpha-receptor variant and two-year memory decline in midlife Australian women.
Chad A Bousman, Cassandra Szoeke, +3 authors, Ian P Everall.
Neuropsychobiology, 2012 Nov 07; 66(4). PMID: 23128795
A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.
Steven P Linke, Troy M Bremer, +2 authors, Cornelius Diamond.
Clin Cancer Res, 2006 Feb 21; 12(4). PMID: 16489071
Genetic variation in the Nrf2 promoter associates with defective spermatogenesis in humans.
Bolan Yu, Huanlan Lin, +6 authors, Zhaofeng Huang.
J Mol Med (Berl), 2012 Jun 01; 90(11). PMID: 22648520
Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial.
P-L Jerevall, X-J Ma, +9 authors, O Stål.
Br J Cancer, 2011 May 12; 104(11). PMID: 21559019    Free PMC article.
Glutathione: toxicological implications.
D J Reed.
Annu Rev Pharmacol Toxicol, 1990 Jan 01; 30. PMID: 2188580
Highly Cited. Review.
A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk.
Irina U Agoulnik, Xiao-Wen Tong, +6 authors, Dirk G Kieback.
J Clin Endocrinol Metab, 2004 Dec 08; 89(12). PMID: 15579801
A double hit implicates DIAPH3 as an autism risk gene.
J A S Vorstman, E van Daalen, +12 authors, R A Ophoff.
Mol Psychiatry, 2010 Mar 24; 16(4). PMID: 20308993    Free PMC article.
Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.
Eunjung Lee, Chris Hsu, +8 authors, Giske Ursin.
Carcinogenesis, 2010 Jun 16; 31(8). PMID: 20547493    Free PMC article.
Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women.
Kristine Yaffe, Li Yung Lui, +2 authors, Philip Morin.
Biol Psychiatry, 2002 Apr 17; 51(8). PMID: 11955468
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking.
Tim A Ahles, Yuelin Li, +5 authors, Andrew J Saykin.
Psychooncology, 2014 May 03; 23(12). PMID: 24789331    Free PMC article.
Moderating Effects of Genetic Polymorphisms on Improvements in Cognitive Impairment in Breast Cancer Survivors Participating in a 6-Week Mindfulness-Based Stress Reduction Program.
Cecile A Lengacher, Richard R Reich, +6 authors, Jong Y Park.
Biol Res Nurs, 2015 Apr 18; 17(4). PMID: 25882604
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
Terence Ng, Shu Mei Teo, +21 authors, Alexandre Chan.
Neuro Oncol, 2015 Aug 21; 18(2). PMID: 26289590    Free PMC article.
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk.
Nady Roodi, William D Dupont, Jason H Moore, Fritz F Parl.
Cancer Res, 2004 Feb 20; 64(4). PMID: 14973116
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers.
T W Robbins, M James, +3 authors, P Rabbitt.
Dementia, 1994 Sep 01; 5(5). PMID: 7951684
Highly Cited.
Regulation of ischemic neuronal death by E2F4-p130 protein complexes.
Grace O Iyirhiaro, Yi Zhang, +9 authors, David S Park.
J Biol Chem, 2014 May 16; 289(26). PMID: 24828495    Free PMC article.
Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause.
Victor W Henderson, Jan A St John, +8 authors, Wendy J Mack.
Proc Natl Acad Sci U S A, 2013 Nov 28; 110(50). PMID: 24277815    Free PMC article.
Polymorphisms in DNA repair and oxidative stress genes associated with pre-treatment cognitive function in breast cancer survivors: an exploratory study.
Theresa A Koleck, Catherine M Bender, +6 authors, Yvette P Conley.
Springerplus, 2016 Apr 22; 5. PMID: 27099827    Free PMC article.
Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study.
Kristine Yaffe, Karla Lindquist, +6 authors, Steven R Cummings.
Neurobiol Aging, 2007 Sep 25; 30(4). PMID: 17889406    Free PMC article.
Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
David Barzan, Marlon R Veldwijk, +6 authors, Frederik Wenz.
Eur J Hum Genet, 2013 Mar 15; 21(11). PMID: 23486537    Free PMC article.
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
Rebecca Hein, Melanie Maranian, +169 authors, Alison M Dunning.
PLoS One, 2012 Aug 11; 7(8). PMID: 22879957    Free PMC article.
Med Clin North Am, 1963 Nov 01; 47. PMID: 14078168
Highly Cited.
Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
H Kawamoto, H Koizumi, T Uchikoshi.
Am J Pathol, 1997 Jan 01; 150(1). PMID: 9006317    Free PMC article.
The conserved mitochondrial twin Cx9C protein Cmc2 Is a Cmc1 homologue essential for cytochrome c oxidase biogenesis.
Darryl Horn, Wen Zhou, +4 authors, Antoni Barrientos.
J Biol Chem, 2010 Mar 12; 285(20). PMID: 20220131    Free PMC article.
Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients.
Troy M Bremer, Jocelyne Jacquemier, +3 authors, Steven P Linke.
Int J Cancer, 2008 Nov 28; 124(4). PMID: 19035452
Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.
Tim A Ahles, James C Root, Elizabeth L Ryan.
J Clin Oncol, 2012 Sep 26; 30(30). PMID: 23008308    Free PMC article.
Highly Cited. Review.
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline.
Carolyn D Runowicz, Corinne R Leach, +13 authors, Patricia A Ganz.
J Clin Oncol, 2015 Dec 09; 34(6). PMID: 26644543
Highly Cited. Systematic Review.
Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.
Ting Liu, Lilan Chen, +7 authors, Wen Di.
Tumour Biol, 2013 Nov 08; 35(3). PMID: 24197980
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.
Grace M Callagy, Mark J Webber, Paul D P Pharoah, Carlos Caldas.
BMC Cancer, 2008 May 31; 8. PMID: 18510726    Free PMC article.
Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.
Aderbal R T Silva, Ana Cecília Feio Santos, +10 authors, Helena Brentani.
PLoS One, 2014 Jun 18; 9(6). PMID: 24936870    Free PMC article.
Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes.
Chantel D Sloan, Li Shen, +12 authors, Andrew J Saykin.
Am J Med Genet B Neuropsychiatr Genet, 2010 May 15; 153B(5). PMID: 20468060    Free PMC article.
Two common SNPs in pri-miR-125a alter the mature miRNA expression and associate with recurrent pregnancy loss in a Han-Chinese population.
Yi Hu, Chun-Mei Liu, +7 authors, Xu Ma.
RNA Biol, 2011 Jul 27; 8(5). PMID: 21788734
Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer.
Tarek M A Abdel-Fatah, Desmond G Powe, +5 authors, Ian O Ellis.
J Pathol, 2010 Oct 06; 222(4). PMID: 20922713
Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis.
Z E Winters, N C Hunt, +4 authors, C J Norbury.
Eur J Cancer, 2001 Nov 27; 37(18). PMID: 11720835
The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone.
Andrea Romano, Bert Delvoux, Dagmar-Christiane Fischer, Patrick Groothuis.
J Mol Endocrinol, 2007 Feb 13; 38(1-2). PMID: 17293450
Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.
Jeffrey S Wefel, Shelli R Kesler, Kyle R Noll, Sanne B Schagen.
CA Cancer J Clin, 2014 Dec 09; 65(2). PMID: 25483452    Free PMC article.
Highly Cited. Review.
Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level.
Theresa A Koleck, Yvette P Conley.
Breast Cancer (Dove Med Press), 2016 Mar 30; 8. PMID: 27022301    Free PMC article.
A five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifen.
Daniel Alan Kerr, James L Wittliff.
Horm Cancer, 2011 Aug 10; 2(5). PMID: 21826535
Candidate mechanisms for chemotherapy-induced cognitive changes.
Tim A Ahles, Andrew J Saykin.
Nat Rev Cancer, 2007 Feb 24; 7(3). PMID: 17318212    Free PMC article.
Highly Cited. Review.
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk.
R Schwab, R Bussolari, +12 authors, A Sala.
Oncogene, 2007 Nov 21; 27(20). PMID: 18026132
Progesterone receptors: form and function in brain.
Roberta Diaz Brinton, Richard F Thompson, +8 authors, Jon Nilsen.
Front Neuroendocrinol, 2008 Apr 01; 29(2). PMID: 18374402    Free PMC article.
Highly Cited. Review.
Altered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breasts.
A J Batchelder, A N Gordon-Weeks, R A Walker.
Breast Cancer Res Treat, 2008 Mar 28; 114(1). PMID: 18368476
Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers.
Jamunarani Veeraraghavan, Ying Tan, +11 authors, Xiao-Song Wang.
Nat Commun, 2014 Aug 08; 5. PMID: 25099679    Free PMC article.
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Bin Wang, Chin-Jung Hsu, +4 authors, Chih-Hsin Tang.
Int J Med Sci, 2018 May 05; 15(6). PMID: 29725257    Free PMC article.
Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.
Mackenzi Pergolotti, Nicolò Matteo Luca Battisti, +12 authors, Tim A Ahles.
J Geriatr Oncol, 2019 Oct 18; 11(2). PMID: 31619372    Free PMC article.
Genetic Modulation of Neurocognitive Development in Cancer Patients throughout the Lifespan: a Systematic Review.
Charlotte Sleurs, Aline Madoe, +4 authors, Anne Uyttebroeck.
Neuropsychol Rev, 2019 Mar 31; 29(2). PMID: 30927148
Systematic Review.
Novel candidate biomarkers of origin recognition complex 1, 5 and 6 for survival surveillance in patients with hepatocellular carcinoma.
Xiang-Kun Wang, Qiao-Qi Wang, +11 authors, Tao Peng.
J Cancer, 2020 Mar 21; 11(7). PMID: 32194798    Free PMC article.
AURKA rs2273535 T>A Polymorphism Associated With Cancer Risk: A Systematic Review With Meta-Analysis.
Shujie Wang, Jian Qi, +2 authors, Jinfu Nie.
Front Oncol, 2020 Aug 01; 10. PMID: 32733797    Free PMC article.
Systematic Review.
Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.
Chun-Yu Hsieh, Ying-Erh Chou, +6 authors, Shun-Fa Yang.
Int J Environ Res Public Health, 2020 Nov 25; 17(22). PMID: 33228130    Free PMC article.
Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.
Yulong Bao, Li Wang, +6 authors, Yongfeng Jia.
Cell Mol Biol Lett, 2019 Jun 12; 24. PMID: 31182966    Free PMC article.
Highly Cited.
Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Soo-Cheen Ng, Po-Hui Wang, +4 authors, Yi-Hsuan Hsiao.
Int J Med Sci, 2019 Jul 25; 16(6). PMID: 31337950    Free PMC article.